LAPTM4B and osteosarcoma: To further evaluate the potential involvement of LAPTM4B in osteosarcoma development, the expression of LAPTM4B was depleted by the transfection of its shRNA plasmids in two types of osteosarcoma cell lines: MG‐63 and U‐2 OS, respectively.